|
Market Closed -
Nasdaq
00:00:00 24/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 19.84 USD | -2.17% |
|
-1.24% | -41.66% |
Company Valuation: Assembly Biosciences, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111.5 | 63.41 | 53.96 | 100.3 | 537.9 | 404 | - | - |
| Change | - | -43.14% | -14.91% | 85.89% | 436.32% | -24.91% | - | - |
| Enterprise Value (EV) 1 | 111.5 | 63.41 | 53.96 | 100.3 | 537.9 | 317.5 | 277.1 | 165.3 |
| Change | - | -43.14% | -14.91% | 85.89% | 436.32% | -40.98% | -12.73% | -40.34% |
| P/E | -0.78x | -0.68x | -0.74x | -2.36x | -61.8x | -170x | -7.27x | -15.4x |
| PBR | - | - | - | - | - | 0.97x | 1.04x | 0.91x |
| PEG | - | 0x | 0x | 0x | 0.7x | 2.2x | -0x | 0.3x |
| Capitalization / Revenue | 17.8x | - | 7.53x | 3.52x | 7.44x | 6.37x | 11.8x | 8.28x |
| EV / Revenue | 17.8x | - | 7.53x | 3.52x | 7.44x | 5.01x | 8.12x | 3.39x |
| EV / EBITDA | - | - | - | - | -44.9x | 9.04x | -9.1x | -10.5x |
| EV / EBIT | -1.22x | -0.67x | -0.83x | -2.21x | -44.4x | -14.9x | -4.06x | -5.07x |
| EV / FCF | - | -0.75x | - | - | -13.1x | 33.1x | 14.8x | 3.88x |
| FCF Yield | - | -133% | - | - | -7.65% | 3.02% | 6.75% | 25.8% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -36 | -23.04 | -13.38 | -6.69 | -0.55 | -0.1165 | -2.728 | -1.284 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 6.254 | - | 7.163 | 28.52 | 72.3 | 63.43 | 34.12 | 48.78 |
| EBITDA 1 | - | - | - | - | -11.99 | 35.11 | -30.44 | -15.7 |
| EBIT 1 | -91.05 | -94.11 | -64.65 | -45.42 | -12.12 | -21.37 | -68.29 | -32.64 |
| Net income 1 | -129.9 | -93.09 | -61.23 | -40.18 | -6.122 | 1.403 | -56.83 | -27.27 |
| Net Debt 1 | - | - | - | - | - | -86.48 | -126.9 | -238.6 |
| Reference price 2 | 27.96 | 15.60 | 9.84 | 15.78 | 34.01 | 19.84 | 19.84 | 19.84 |
| Nbr of stocks (in thousands) | 3,988 | 4,065 | 5,483 | 6,356 | 15,817 | 20,361 | - | - |
| Announcement Date | 11/03/22 | 22/03/23 | 28/03/24 | 20/03/25 | 19/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -170.32x | 5.01x | 9.04x | - | 404M | |
| 18.83x | 6.63x | 13.18x | 1.58% | 64.69B | |
| 30.16x | 8x | 26.2x | 0.05% | 54.78B | |
| 36.79x | 6.53x | 19.51x | 0.88% | 53.49B | |
| 35.59x | 3.45x | 14.87x | -.--% | 45.98B | |
| 49.71x | 5.74x | 31.52x | -.--% | 42.94B | |
| -19.41x | 187.75x | -20.66x | -.--% | 40.08B | |
| 28.93x | 8.21x | 21.27x | 0.37% | 33.52B | |
| 27.67x | 5.83x | 15.12x | -.--% | 23.97B | |
| 32.66x | 5.97x | 20.09x | -.--% | 23.67B | |
| Average | 7.06x | 24.31x | 15.02x | 0.32% | 38.35B | |
| Weighted average by Cap. | 26.51x | 25.30x | 15.89x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ASMB Stock
- Valuation Assembly Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
